டான் சிரோட்டானு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டான் சிரோட்டானு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டான் சிரோட்டானு Today - Breaking & Trending Today

Vivo Capital and an Investor Syndicate Completes Sale of Surgical Specialties Corporation to GTCR-ba


Search jobs
01-Feb-2021
Vivo Capital and an Investor Syndicate Completes Sale of Surgical Specialties Corporation to GTCR-backed Corza Health
PALO ALTO, Calif. (BUSINESS WIRE) Vivo Capital, a global healthcare investment firm, announced today that it has closed the sale of Surgical Specialties Corporation (“SSC”) to Corza Health, a portfolio company of GTCR, a global private equity firm.
Vivo Capital and an investor syndicate including certain Vivo limited partner co-investors acquired SSC, a global manufacturer and leader in the medical device consumables segment, in 2017. Since then, SSC has acquired three companies, divested one product line to Angiodynamics, and built two factories in the US and China while reinvigorating the company’s iconic brands, including Quill™ and Sharpoint™. ....

United States , Palo Alto , Shan Fu , Frank Kung , Latham Watkins , Dan Croteau , Piper Sandler , Corza Health , Vivo Fund , Surgical Specialties Corporation , Vivo Capital , Managing Partner , ஒன்றுபட்டது மாநிலங்களில் , பாலோ ஆல்டோ , ஷான் ஃபூ , வெளிப்படையான குங் , லாதம் வாட்கின்ஸ் , டான் சிரோட்டானு , பைபர் சாண்ட்லர் , விவோ நிதி , அறுவை சிகிச்சை சிறப்பு நிறுவனம் , விவோ மூலதனம் , நிர்வகித்தல் கூட்டாளர் ,

GTCR and Gregory T. Lucier Announce Merger of Surgical Specialties and TachoSil to Create Corza Medical


Press release content from PR Newswire. The AP news staff was not involved in its creation.
GTCR and Gregory T. Lucier Announce Merger of Surgical Specialties and TachoSil to Create Corza Medical
February 1, 2021 GMT
CHICAGO and WESTWOOD, Mass., Feb. 1, 2021 /PRNewswire/ GTCR, a leading private equity firm, announced today that its management partnership with Gregory T. Lucier, Corza Health, has simultaneously acquired and merged Surgical Specialties Corporation (“Surgical Specialties”) and the TachoSil® Fibrin Sealant Patch (“TachoSil”) to create a new company, Corza Medical. Surgical Specialties is a medical technology company focused on high-performance surgical sutures and ophthalmic knives. TachoSil, previously owned by Takeda Pharmaceutical Company Limited, is a differentiated surgical patch product line used to enable safe and fast bleeding control during surgeries. ....

United States , Kellie Kennedy , Dan Croteau , Kirkland Ellis , Gregoryt Lucier , Media Telecommunications , Financial Services Technology , Corza Health , Surgical Specialties Corporation , Growth Business Services , Takeda Pharmaceutical Company , Fibrin Sealant Patch , Surgical Specialties , Takeda Pharmaceutical Company Limited , Executive Chairman Gregory , Chief Executive Officer Dan Croteau , Corza Medical , Dean Mihas , Managing Director , North America , Financial Services , Leaders Strategy , ஒன்றுபட்டது மாநிலங்களில் , கெளிலிே கெந்நெடீ , டான் சிரோட்டானு , கர்க்‌ல்யாஂட் நீள்வட்டம் ,

GTCR and Gregory Lucier Form Corza Medical


GTCR and Gregory Lucier Form Corza Medical
Private equity firm
Surgical Specialties Corp. and the
TachoSil Fibrin Sealant Patch to create a new company called
Corza Medical.
Surgical Specialties is a medical technology company focused on surgical sutures and ophthalmic knives. TachoSil, previously owned by
Takeda Pharmaceutical Co. Ltd., is a surgical patch product line used to enable bleeding control during surgeries.
The company will be led by executive chairman Gregory Lucier and CEO 
Dan Croteau, with a global team of over 1,700 employees supporting clinicians, distributors and medical device companies. Corza Medical will provide healthcare professionals a platform of surgical technologies with brands including ....

United States , Dan Croteau , Gregory Lucier , Kirkland Ellis , Takeda Pharmaceutical Co , Surgical Specialties Corp , Surgical Specialties , Tachosil Fibrin Sealant Patch , Takeda Pharmaceutical , Sharpoint Plus , North America , ஒன்றுபட்டது மாநிலங்களில் , டான் சிரோட்டானு , கிரெகொரி லூசியர் , கர்க்‌ல்யாஂட் நீள்வட்டம் , டாகேடா மருந்து இணை , அறுவை சிகிச்சை சிறப்பு கார்ப் , அறுவை சிகிச்சை சிறப்பு , டாகேடா மருந்து , வடக்கு அமெரிக்கா ,

Charlesbank Buys Stake in MB2 Dental from Sentinel


Charlesbank Buys Stake in MB2 Dental from Sentinel
Charlesbank Capital Partners, a middle-market private investment firm, announced that an affiliated fund has made a significant growth investment in
MB2 Dental, acquiring a majority interest from funds affiliated with
Sentinel Capital Partners and management.
Founded in 2007, MB2 Dental is a dental partnership organization with affiliated practices across 24 states. The remaining stake in MB2 is held by CEO and founder,
Dr. Chris Steven Villanueva, management and its doctor owners, who reinvested a substantial percentage of their equity.
Brandon White, managing director at Charlesbank, says, “We see significant M&A opportunity in the fragmented dental services market, and we believe that our investment will enable MB2 to accelerate its proven acquisition strategy as well as continue to develop its suite of shared services to support value creation.” ....

United States , Dan Croteau , Gregory Lucier , Kirkland Ellis , Takeda Pharmaceutical Co , Surgical Specialties Corp , Surgical Specialties , Tachosil Fibrin Sealant Patch , Takeda Pharmaceutical , Sharpoint Plus , North America , ஒன்றுபட்டது மாநிலங்களில் , டான் சிரோட்டானு , கிரெகொரி லூசியர் , கர்க்‌ல்யாஂட் நீள்வட்டம் , டாகேடா மருந்து இணை , அறுவை சிகிச்சை சிறப்பு கார்ப் , அறுவை சிகிச்சை சிறப்பு , டாகேடா மருந்து , வடக்கு அமெரிக்கா ,